• SmD2 Acetylation Links HCC Splicing to PARP Sensitivity

  2026-09-23

  This study identifies an acetylation-controlled role for the spliceosome protein SmD2 in hepatocellular carcinoma (HCC): HDAC2-mediated deacetylation stabilizes SmD2, which influences BRCA1/FANC cassette-exon processing and DNA-damage repair. Disrupting this pathway, including with Romidepsin alongside the PARP inhibitor olaparib, sensitized HCC models to PARP inhibition and suggests a preclinical strategy for tumors without established BRCA deficiency.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-09-23

  This study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon processing, and DNA-damage repair in hepatocellular carcinoma. Its findings support combining HDAC2-directed intervention with PARP inhibition to increase treatment sensitivity in HCC models.

• Cholesterol: From Membrane Variable to Assay Insight

  2026-09-22

  Cholesterol is the principal sterol for interpreting membrane behavior, lipid metabolism research, and delivery-associated cell responses. This article presents a causal assay framework that distinguishes direct cholesterol effects from lipid nanoparticle and p21 mRNA biology.

• AMC-Hem Illuminates Real-Time HO-1 Regulation

  2026-09-22

  The reference study introduces AMC-Hem, a red-shifted aminocoumarin–heme fluorescent probe designed to report heme oxygenase-1 activity rather than simply protein abundance. In live human macrophages and serum, the probe revealed compartmentalized HO-1 activity, non-transcriptional regulation by small molecules, and a practical route toward dynamic biochemical measurements.

• DiscoveryProbe Metabolism Library: Assay Logic

  2026-09-21

  The DiscoveryProbe Metabolism-related Compound Library supports mechanism-led metabolic screening rather than simple compound enumeration. This article shows how its chemical diversity can be mapped onto redox, lipid, and PPAR signaling assays using insights from a cardiac ANP study.

• GSK343: Reframing EZH2 Inhibition for Translation

  2026-09-21

  GSK343 offers a precise way to interrogate EZH2-dependent chromatin repression while keeping translational conclusions appropriately bounded. By connecting PRC2 biology with emerging evidence that APEX2 supports TERT expression through DNA repair at repetitive regions, this article outlines a practical strategy for moving from target engagement to mechanistic insight in epigenetic cancer research.

• Valemetostat (DS-3201) Research Workflow

  2026-09-20

  Build a translational Valemetostat workflow that connects EZH2 genotype, PRC2 target engagement, and lymphoma-cell response. The guide separates evidence from optimization advice, helping researchers use this selective epigenetic probe in EZH2 mutant inhibition, follicular lymphoma, and broader lymphoma studies.

• Primidone: From Target Assays to Translational Design

  2026-09-19

  Primidone and Mysoline are more than established neurological medicines: they are useful probes for TRPM3, RIPK1, and selected enzyme assays. This evidence-led guide shows how to connect biochemical potency, assay architecture, model dosing, and translational interpretation without confusing mechanistic plausibility with therapeutic proof.

• Toremifene in Breast Cancer: 20-Year Evidence Review

  2026-09-18

  This review examines how two decades of clinical and translational evidence position toremifene as an oral selective estrogen receptor modulator for hormone receptor–positive breast cancer. Its main contribution is a clinically focused synthesis showing broadly comparable efficacy with tamoxifen, no confirmed overall safety advantage, and a distinct pharmacokinetic profile that may inform treatment selection in selected postmenopausal patients.

• From Reporter Signal to Translational mRNA Insight

  2026-09-18

  A mechanistic and strategic guide to using EZ Cap™ Firefly Luciferase mRNA as a calibrated reporter for mRNA delivery, translation, gene regulation, and in vivo imaging—while accounting for formulation, route, inflammation, and biological context.

• Mouse Toxicology of Decitabine: Methods and Findings

  2026-09-17

  Momparler and Frith established a route-relevant mouse toxicology framework for 5-Aza-2'-deoxycytidine, combining continuous intravenous infusion, sex-specific lethality estimates, and histopathology during acute injury and recovery. The study showed dose-limiting hematopoietic and gastrointestinal toxicity that was largely reversible, while persistent leukopenia highlighted the need for exposure-aware experimental design.

• Rocilinostat (ACY-1215) Workflow Guide

  2026-09-17

  Build selective HDAC6 experiments around α-tubulin acetylation, multiple myeloma viability, and proteasome-inhibitor combinations. This guide also shows how to extend Rocilinostat research into primary-cilia questions without confusing exploratory assays with findings established in SMPD4 developmental models.

• PARP1–FAK–COL5A1 Signaling in Ovarian Cancer

  2026-09-16

  A 2024 Cellular Signalling study established a cholesterol-resistant ovarian cancer model and identified a PARP1–FAK/Src–COL5A1 axis that promotes epithelial–mesenchymal transition. Its combined adaptation, pathway perturbation, tissue analysis, and in vivo design provides a useful framework for cancer biology research focused on cholesterol-linked invasion and tumor progression.

• How EZH2 Shapes eIF4F Inhibitor Resistance in Melanoma

  2026-09-16

  The reference study identifies EZH2 and AKT1 signaling as coordinated resistance nodes that emerge after eIF4F-complex inhibition in BRAFV600E melanoma models. Its time-resolved experiments show why combining eIF4F, EZH2, and AKT1 inhibition can improve activity against both eIF4F inhibitor resistance and vemurafenib resistance.

• Pazopanib in ATRX-Defined Glioma Research

  2026-09-15

  Pazopanib (GW-786034) offers a genotype-aware tool for studying RTK dependence, angiogenesis inhibition, and tumor growth suppression in glioma models. This article translates ATRX-sensitive inhibitor findings into practical assay-design and interpretation strategies.

8661 records 1/578 page Next 12345 下5页 Last page